The Innovative Medicines Initiative (IMI) is Europe’s biggest public-private partnership, jointly undertaken by the European Union and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The goal of the IMI public-private partnership is to facilitate collaboration between key players in healthcare research including, but not limited to, patient organizations, universities and pharmaceuticals, and thereby [...]

Public perception of brain research is a field that had hardly been investigated. Whilst EBC’s network is made up of members and people who are all highly engaged in brain related issues and who all find brain research salient, a recent article by O’Connor and Joffe argues that brain research receive very little interest or [...]

As part of its Year of the Brain, the European Brain Council (EBC) hosted a satellite event on Atrial Fibrillation-related stroke prevention in parallel to the EU Chronic Disease Summit, having identified stroke as one of the few brain diseases where better prevention can measurably improve health outcomes and significantly reduce the EU’s chronic disease [...]

EBC Vice President Professor David Nutt is the winner of the 2013 John Maddox Prize for Standing up for Science. The international prize is awarded for courage in promoting science and evidence on a matter of public interest, despite facing difficulty and hostility in doing so. The judges awarded the prize to Professor Nutt in recognition [...]